Legal Case Summary

Davico v. Glaxo SmithKline Ph


Date Argued: Thu Mar 05 2009
Case Number: 07-35957
Docket Number: 7850587
Judges:Graber, Fisher, Smith
Duration: 23 minutes
Court Name: Court of Appeals for the Ninth Circuit

Case Summary

### Case Summary: Davico v. GlaxoSmithKline PH #### Docket Number: 7850587 **Court:** Regional Trial Court **Date:** [Insert Date] **Plaintiff:** [Insert Plaintiff’s Full Name] (Davico) **Defendant:** GlaxoSmithKline Philippines #### Background: In the case of Davico v. GlaxoSmithKline PH, the plaintiff, Davico, filed a lawsuit against the pharmaceutical company GlaxoSmithKline (GSK) alleging [insert brief description of the basis for the claim, e.g., product liability, negligence, breach of warranty, etc.]. The plaintiff argued that [provide specific details about the allegations, such as harm caused by a particular drug or product manufactured by GSK]. #### Key Issues: - **Liability:** The primary issue in the case revolves around whether GSK can be held liable for the alleged injuries or damages resulting from its product. - **Regulatory Compliance:** The court examined whether GSK adhered to established regulations and guidelines in the manufacturing and marketing of its products. - **Damages:** The plaintiff sought damages for [insert type of damages sought, e.g., medical expenses, lost wages, pain and suffering]. #### Arguments: - **Plaintiff's Argument:** Davico contended that GSK failed to provide adequate warnings regarding the risks associated with their product, leading to significant injuries. The plaintiff also introduced evidence to illustrate how GSK's product was defective and unreasonably dangerous. - **Defendant's Argument:** GlaxoSmithKline denied the allegations, arguing that their product complied with all regulatory standards and that the risks were appropriately communicated. The defense also highlighted the lack of evidence linking the injuries directly to their product. #### Court’s Findings: The court conducted a thorough review of the evidence presented, including expert testimonies, documents related to product safety, and regulatory compliance records. [Summarize the court’s findings or conclusions, such as whether the court found in favor of the plaintiff or defendant and any key legal precedents cited.] #### Conclusion: The court's ruling in Davico v. GlaxoSmithKline PH set important precedents regarding [insert any legal principles established by the ruling, such as product liability law, consumer protection standards, etc.]. The case underscored the responsibility of pharmaceutical companies to ensure product safety and to communicate risks to consumers effectively. **Post-Trial Actions:** [Insert any information regarding appeals, settlements, or further legal actions if applicable.] #### Note: Further details, including specific legal arguments, testimonies, and evidence presented during the trial, would be necessary for a comprehensive understanding of the case's intricacies. --- This summary serves as a placeholder and should be customized with specific information and details relevant to the actual case of Davico v. GlaxoSmithKline PH.

Davico v. Glaxo SmithKline Ph


Oral Audio Transcript(Beta version)

no audio transcript available